• Home
  • Company
    • Mission
    • Management Team
    • Locations
    • Investors
    • Awards
  • Products
    • Product Overview
    • Bafasal®
    • Bafador®
    • Product Pipeline
  • Strategy
    • Strategic Goals
  • Partnering
    • Co-Development
    • Become a Distributor
    • Grants
  • Sustainability
    • Sustainability Overview
    • Reports
  • Media
    • Events & Presentations
    • News
  • COVID-19
  • Contact
Proteon-Award2-speech
April 8, 2019

Proteon Founder, Professor Jarosław Dastych, presents on “Aquaculture: Challenges and Lessons of Product Development” at the Bacteriophage Therapy Summit, Boston, USA.

Maria Rojek-Lucas Company News

Proteon Founder and Board Member, Professor Jarosław Dastych, made a major presentation at the Bacteriophage Therapy Summit in  Boston, USA. He spoke on the  topic  of ” Aquaculture: Challenges and Lessons of Product Development” The Bacteriophage Therapy Summit is the only meeting uniting large pharma, biotech companies, research institutions and technology experts to harness bacteriophage science and accelerate the clinical […]

Read More

Proteon-Award
April 8, 2019

Proteon receives the “Best Innovation in Aquaculture Award” at the Global Forum for Innovations in Agriculture (GFIA)

Maria Rojek-Lucas Company News

Proteon received the Best “Innovation in Aquaculture Award”, from His Excellency, Saeed Albahri Salem Alameri, and Hans van der Beek, Director General of the Abu Dhabi Agriculture and Food Safety Authority at the Global Forum for Innovations in Agriculture (GFIA) in Abu Dhabi. Tom Cook, VP. Global Business Development at Proteon Pharmaceuticals, accepted the award. The […]

Read More

January 24, 2019

Proteon Pharmaceuticals is Fighting Salmonella by Attacking it on the Farm

Maria Rojek-Lucas Company News

Proteon Pharmaceuticals COO Matthew Tebeau sat down with Christine Corrado from Proactive Investors at the 11th Annual BioTech Showcase in San Francisco. The Poland-based biotech aims to reduce reliance on antibiotics by using naturally-occurring bacteriophages to prevent and treat infectious diseases.

Read More

July 17, 2018

Proteon Pharmaceuticals gives an extensive comment on Salmonella issue in Poland in a video interview for a Polish business wire agency

Justyna Grzelak Company News

Cases of salmonellosis are a growing problem – their number has been steadily growing for the last two years exceeding the number of 10 thousand cases per year. One of the main sources of infection are eggs and poultry. Few months ago new set of rules was implemented regarding national program for the control of […]

Read More

May 16, 2018

Proteon Pharmaceuticals was invited to present its bacteriophage technology at the prestigious animal nutrition conference FIAAP in Bangkok

Justyna Grzelak Company News

Proteon Pharmaceuticals was an invited speaker at the 9th edition of the FIAAP Animal Nutrition conference held on March 27, 2018 in Bangkok, Thailand. This one-day international conference highlighted the latest innovations and research in animal feed ingredients and additives. The event was co-located with five additional conferences as part of VICTAM Asia 2018. (more…)

Read More

October 24, 2017

Proteon Pharmaceuticals attracts environmental impact investment fund

Justyna Grzelak Company News

October 24, 2017  – Proteon Pharmaceuticals S.A., a Polish biotechnology firm has signed an agreement with an international Investment Fund, the Aqua-Spark fund, which invests in sustainable aquaculture. Proteon Pharmaceuticals will use the funds to commercialize its products globally, develop production capacity and support the development of its bacteriophage-platform technology. Proteon Pharmaceuticals is a world […]

Read More

July 3, 2017

BAFADOR® presented at the international bacteriophage conference in Tbilisi

Justyna Grzelak Company News

Proteon Pharmaceuticals presents its unique product BAFADOR® at the international bacteriophage conference in Tbilisi Proteon Pharmaceuticals participated in the international conference “Centennial Celebration of Bacteriophage Research”, held in Tbilisi, Georgia on June 26-29, 2017. Proteon Pharmaceuticals’ R&D Director, Dr Ewelina Wójcik, presented the results of Company’s research, which has led to development of a phage-based […]

Read More

February 6, 2017

Proteon Pharmaceuticals awarded grants for Euro 3.2 m

Justyna Grzelak Company News

In 2016 Proteon Pharmaceuticals awarded grants from Polish Center for Research & Development for Euro 3.2 m In 2016, Proteon Pharmaceuticals signed the agreements for the co-financing five research projects from the European Union for Euro 3.2 million. The projects are for research and development of new generation, innovative products, based on our unique phage-platform […]

Read More

Categories

  • Company News (17)
  • Proteon General News (1)

Recent Posts

  • Proteon Pharmaceuticals and Skretting to co-develop new phage-based solutions for aquaculture
  • Proteon Pharmaceuticals – strategiczne partnerstwo handlowe z DuPont Animal Nutrition
  • Proteon Pharmaceuticals announces a strategic partnership in distribution with DuPont Animal Nutrition
  • Addressing the Superbug Concern: Phage Therapy Could Beat Drug Resistant Illnesses
  • Proteon Pharmaceuticals Joins Research Efforts to Fight Coronavirus

Our Solutions

170131_salmonellafree_logo_456x181-e1486970860523

Contact Proteon

Follow Us —

Company

  • Mission
  • Management Team
  • Locations
  • Investors
  • Awards

Products

  • Product Overview
  • Bafasal®
  • Bafador®
  • Product Pipeline

Partnering

  • Co-Development
  • Become a Distributor
  • Grants

Strategy

  • Strategic Goals

Sustainability

  • Overview
  • Reports

Media

  • Events & Presentations
  • Media About Us
  • News
logo_proteon-white

CUSTOMER SERVICE:    +48 502-678-674     |     proteon@proteonpharma.com

Privacy Policy | Polityka Prywatności

Copyright © 2019 Proteon Pharmaceuticals, All Rights Reserved